Vision benefits company XP Health raises $17.1M and more digital health fundings

XP Well being, an organization growing a digital-first imaginative and prescient advantages platform, raised $17.1 million in a Collection A funding spherical led by HC9 Ventures, Valor Capital Group and ManchesterStory. 

Further traders embrace Core Innovation Capital, GSR Ventures, Canvas Ventures, Plug and Play, CameronVC, Ken Goulet, Kevin Hill, Jeff Epstein and Brett Rochkind. This latest funding spherical adopted a $5.5 million elevate in 2021.

“This spherical of funding permits us to strengthen the platform’s performance and supply a stellar client expertise in essentially the most reasonably priced strategy to employers, insurance coverage carriers and workers,” Antonio Moraes, cofounder and CEO of XP Well being, mentioned in a press release.

“We have now a game-changing providing for the way individuals entry and expertise worker advantages – with an final purpose to positively influence lots of of hundreds of thousands of lives by means of high-quality, accessible and reasonably priced well being advantages.”

Lung-health firm Optellum introduced closing a $14 million Collection A funding spherical led by U.Okay. enterprise capital agency Mercia with participation from U.S. corporations Intuitive Ventures and Black Opal.

Its Digital Nodule Clinic software program is used to trace, assess and characterize nodules within the lungs. The corporate attained FDA clearance within the U.S., CE-MDR within the European Union, and UKCA in the UK for the platform. A CE mark certificates (CE-MDR) is required to commercialize medical units within the EU. The U.Okay. Conformity Assessed marking signifies a product conforms with relevant necessities to be bought in Nice Britain.

“[Virtual Nodule Clinic] might help physicians determine and monitor at-risk sufferers, and optimally diagnose the indicators of lung most cancers early — so therapy may be began sooner for sufferers with tumors, and to attenuate invasive procedures similar to biopsies on benign lesions,” the corporate mentioned in a press launch. 

The corporate behind the Cionic Neural Sleeve obtained $12.5 million in a Collection A funding led by BlueRun Ventures, with participation from EPIC Ventures, LDV Capital, Caffeinated Capital and JobsOhio Progress Capital Fund. 

This spherical of funding follows Cionic Neural Sleeve’s FDA clearance in early 2022. The leg-worn gadget offers electrical stimulation so individuals with foot drop and muscle weak spot can stroll extra simply. Cionic has thus far obtained $23 million to construct its platform centered on human mobility. 

The brand new spherical of funds will assist the corporate develop manufacturing and supply of its mobility know-how, and speed up analysis trials and commercialization of its merchandise for brand spanking new indications. 

“Ahead-looking traders understand that we have to take motion right now, and we’re proud to be backed by a bunch of traders who acknowledge the necessity for higher options and have joined us in our mission to redefine human mobility,” Cionic founder and CEO Jeremiah Robison mentioned in a press release. 

Kaleidoscope, a cloud-based analysis platform that maps knowledge utilization by R&D groups, solidified a $6 million seed financing spherical.

It was co-led by Hummingbird Ventures and Dimension, with participation from SV Angel, Hawktail, Caffeinated Capital and particular person traders.

The funding will assist the corporate additional develop the platform’s product and develop the corporate’s workforce, particularly with software program engineers. 

“The best way individuals work in analysis is altering. Kaleidoscope bridges the hole between groups on a platform that integrates with different software program instruments. The funding will allow us to ship the perfect product and consumer expertise to make analysis extra collaborative, reproducible and scalable,” Bogdan Knezevic, CEO and cofounder of Kaleidoscope, mentioned in a press release.

Arcascope, a well being know-how firm specializing in circadian rhythm disruption, introduced it closed a $2.85 million seed spherical.

The spherical was led by Supermoon Capital, with participation from New Dominion Angels, Inflect Well being, Inception Well being, the Speed up Blue Fund, the Monroe Brown Seed Fund, AIoT Well being, HealthX Ventures and different angel traders. 

The corporate is launching a circadian rhythm administration platform, at the moment accessible through the smartphone app, Shift, to deal with the sleep wants of shift staff. 

Surge, an organization growing machine studying know-how to decode a affected person’s blood pattern to forecast the danger of postoperative problems, proclaims a $2.6 million spherical co-led by HCVC and Boutique Enterprise Companions, with participation by Nicolas Godin. 

The corporate additionally obtained the unique license to the patented postoperative complication prediction know-how from Stanford College, which incorporates 10+ years of analysis on surgical danger prediction. Surge additionally signed a analysis settlement with Stanford aspiring to develop biotech improvements. 

This new spherical of funding will assist the corporate in growing its workforce additional and conducting scientific research with extra hospitals.